Cardinal Health CAH

Cardinal Health Inc · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

$261.93+3.55%close on Nov. 4, 2026 · volume 2.4M · Yahoo Finance

Price, last 52 sessions

$240.00$260.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 4, 2026 · high $261.93 · low $220.22 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 19, 2026Mary C. Scherer
Chief Accounting Officer
Sold2,302$237.39
$237.39-$237.40
$546,473
Aug. 19, 2026Jason M. Hollar
Chief Executive Officer
Sold44,529$236.18
$233.22-$237.88
$10.52 million
Aug. 18, 2026Jason M. Hollar
Chief Executive Officer
Sold80,000$235.74
$234.56-$237.25
$18.86 million
Aug. 18, 2026Stephen M. Mason
CEO, GMPD Segment
Sold35,000$236.40
$234.59-$237.26
$8.27 million
Aug. 18, 2026Deborah Weitzman
CEO, PSS Segment
Sold7,354$235.45
$235.30-$237.44
$1.73 million
Aug. 18, 2026Aaron E. Alt
Chief Financial Officer
Sold42,000$236.34
$234.55-$237.26
$9.93 million
Aug. 18, 2026Jessica L. Mayer
Chief Legal/Compliance Officer
Sold29,436$236.19
$234.64-$237.31
$6.95 million
Aug. 18, 2026Michelle D. Greene
Chief Information Officer
Sold11,650$235.72
$234.57-$237.25
$2.75 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 30 →
  • 8-KNov. 5, 2026, 6:47 a.m. ETView on SEC.govOur explainer

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCardinal Health Q1 FY27 non-GAAP EPS of $3.26 Beats $2.94 Consensus; Raises FY27 Guidance to $12.80-$13.00

  • 8-KOct. 1, 2026, 6:52 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCardinal Health signs binding letter of intent to extend CVS Health distribution agreements through June 2032 and reaffirms FY2027 EPS guidance of $12.40 to $12.60

  • 4Aug. 20, 2026, 4:10 p.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 7:28 a.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 7:30 a.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 7:30 a.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 7:29 a.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 7:29 a.m. ETView on SEC.gov